Both in Pharmaceuticals
Zymeworks vs Sarepta Therapeutics,
Over the past year ZYME returned +57.9% and SRPT returned −1.0%; their daily moves had a correlation of 0.22.
ZYME +57.9% SRPT −1.0%Growth of $1, one year, split-adjusted
| Metric | ZYME | SRPT |
|---|---|---|
| Price | $27.20 | $18.64 |
| Market cap | $1.95B | $1.97B |
| Today | +0.29% | −0.85% |
| 1 month | −3.8% | −10.6% |
| 6 months | +12.4% | −9.0% |
| Year to date | +3.3% | −13.4% |
| 1 year | +63.9% | +1.5% |
| Revenue growth (YoY) | −90.6% | −34.3% |
| Gross margin | 100.0% | 62.8% |
| Net margin | −980.8% | −1.2% |
| P/E (TTM) | — | — |
| Price / sales | 52.6× | 1.0× |
| Net cash | $270.7M | -$59.1M |
| Dividend yield | — | — |
| Volatility (60d) | 46.0% | 62.5% |
| Short % of float | 11.5% | 25.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).